Radiological apoplexy and its correlation with acute clinical presentation, angiogenesis and tumor microvascular density in pituitary adenomas

Journal of Korean Neurosurgical Society

Volumn 50, Issue 4, 2011, Pages 281-287

  Lee, Jung Sup ^a   Park, Yong Sook ^a   Kwon, Jeong Taik ^a   Nam, Taek Kyun ^a   Lee, Tae Jin ^a   Kim, Jae Kyun ^a  

^a Chung Ang University   (South Korea)

Author keywords

Angiogenesis; Microvascular density; Pituitary adenoma; Pituitary apoplexy; Pituitary hemorrhage; VEGF

Indexed keywords

CD31 ANTIGEN; ENDOGLIN; NEUROPILIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; BLOOD VESSEL PARAMETERS; BRAIN CYST; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATIONAL STUDY; FEMALE; HEADACHE; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS APOPLEXY; IMMUNOHISTOCHEMISTRY; MALE; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; QUANTITATIVE STUDY; RETROSPECTIVE STUDY; TUMOR VASCULAR DENSITY; TUMOR VASCULARIZATION; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

EID: 80655131215     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2011.50.4.281     Document Type: Article

References (34)

1. Arita K, Kurisu K, Tominaga A, Sugiyama K, Eguchi K, Hama S, et al.: Relationship between intratumoral hemorrhage and overexpression of vascular endothelial growth factor (VEGF) in pituitary adenoma. Hiroshima J Med Sci 53: 23-27, 2004
2. Banerjee SK, Zoubine MN, Tran TM, Weston AP, Campbell DR: Overexpression of vascular endothelial growth factor164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. Int J Oncol 16: 253-260, 2000
3. Bergers G, Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401-410, 2003
4. Biousse V, Newman NJ, Oyesiku NM: Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry 71: 542-545, 2001
5. Bonneville JF, Cattin F, Gorczyca W, Hardy J: Pituitary microadenomas: early enhancement with dynamic CT--implications of arterial blood supply and potential importance. Radiology 187: 857-861, 1993
6. Ferrara N: Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 25: 581-611, 2004
7. Findling JW, Tyrrell JB, Aron DC, Fitzgerald PA, Wilson CB, Forsham PH: Silent pituitary apoplexy: subclinical infarction of an adrenocorticotropin-producing pituitary adenoma. J Clin Endocrinol Metab 52: 95-97, 1981
8. Garcia de la Torre N, Wass JA, Turner HE: Antiangiogenic effects of somatostatin analogues. Clin Endocrinol (Oxf) 57: 425-441, 2002
9. Gorczyca W, Hardy J: Microadenomas of the human pituitary and their vascularization. Neurosurgery 22: 1-6, 1988
10. Gould VE, Wagner BM: Angiogenesis: an expanding universe. Hum Pathol 33: 1061-1063, 2002
11. Hicklin DJ, Ellis LM: Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23: 1011-1027, 2005
12. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart Nx, /xet-alet al/et-al.: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124, 1992
13. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991
14. Liu ZH, Chang CN, Pai PC, Wei KC, Jung SM, Chen NY, et al.: Clinical features and surgical outcome of clinical and subclinical pituitary apoplexy. J Clin Neurosci 17: 694-699, 2010
15. Lloyd RV, Scheithauer BW, Kuroki T, Vidal S, Kovacs K, Stefaneanu L: Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocr Pathol 10: 229-235, 1999
16. Lohrer P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto Ux, /xet-alet al/et-al.: Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro. Neuroendocrinology 74: 95-105, 2001
17. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA: Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340: 145-146, 1992
18. McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JSx, /xet-alet al/et-al.: Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 87: 4238-4244, 2002
19. Mohr G, Hardy J: Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg Neurol 18: 181-189, 1982
20. Murad-Kejbou S, Eggenberger E: Pituitary apoplexy: evaluation, management, and prognosis. Curr Opin Ophthalmol 20: 456-461, 2009
21. Nawar RN, AbdelMannan D, Selman WR, Arafah BM: Pituitary tumor apoplexy: a review. J Intensive Care Med 23: 75-90, 2008
22. Oh H, Takagi H, Otani A, Koyama S, Kemmochi S, Uemura Ax, /xet-alet al/et-al.: Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): A mechanism contributing to VEGF-induced angiogenesis. Proc Natl Acad Sci U S A 99: 383-388, 2002
23. Ostrov SG, Quencer RM, Hoffman JC, Davis PC, Hasso AN, David NJ: Hemorrhage within pituitary adenomas: how often associated with pituitary apoplexy syndrome? AJR Am J Roentgenol 153: 153-160, 1989
24. Pizarro CB, Oliveira MC, Pereira-Lima JF, Leães CG, Kramer CK, Schuch T, et al.: Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker. Neuropathology 29: 40-44, 2009
25. Semple PL, Jane JA, Lopes MB, Laws ER: Pituitary apoplexy: correlation between magnetic resonance imaging and histopathological results. J Neurosurg 108: 909-915, 2008
26. Tammela T, Enholm B, Alitalo K, Paavonen K: The biology of vascular endothelial growth factors. Cardiovasc Res 65: 550-563, 2005
27. Turgut M, Ozsunar Y, Başak S, Güney E, Kir E, Meteoǧlu I: Pituitary apoplexy: an overview of 186 cases published during the last century. Acta Neurochir (Wien) 152: 749-761, 2010
28. Turner HE, Harris AL, Melmed S, Wass JA: Angiogenesis in endocrine tumors. Endocr Rev 24: 600-632, 2003
29. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA: Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab 85: 1159-1162, 2000
30. Verrees M, Arafah BM, Selman WR: Pituitary tumor apoplexy: characteristics, treatment, and outcomes. Neurosurg Focus 16: E6, 2004
31. Wakai S, Fukushima T, Teramoto A, Sano K: Pituitary apoplexy: its incidence and clinical significance. J Neurosurg 55: 187-193, 1981
32. Wakai S, Yamakawa K, Manaka S, Takakura K: Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance. Neurosurgery 10: 437-444, 1982
33. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409, 1993
34. Yamada S, Takada K: Angiogenesis in pituitary adenomas. Microsc Res Tech 60: 236-243, 2003